Next |
home / stock / rdgl / rdgl message board
Subject | By | Source | When |
---|---|---|---|
Amen to that brother. | Tiger Money | investorshub | 07/03/2024 12:54:14 AM |
*Premiums are calculated from the closing price of | WhAtEvA1 | investorshub | 07/03/2024 12:42:51 AM |
Well said!! | mc73 | investorshub | 07/03/2024 12:07:25 AM |
Not worried about buyouts at the moment. My | Nytoncva | investorshub | 07/02/2024 10:52:07 PM |
With the CREDENTIALS of those we are seemingly | BBANBOB | investorshub | 07/02/2024 10:17:15 PM |
Correct Catfish and rogers711is wrong in my view. | WhAtEvA1 | investorshub | 07/02/2024 8:36:28 PM |
💯 | mc73 | investorshub | 07/02/2024 7:57:36 PM |
Again, its why a BO wouldnt happen until | CatfishHunter | investorshub | 07/02/2024 7:11:10 PM |
Someone correct me if I'm wrong. BO | WhAtEvA1 | investorshub | 07/02/2024 7:05:54 PM |
Rdgl is muito better than the bs on | Truthsocial | investorshub | 07/02/2024 7:01:11 PM |
Nobody is purchasing a company (that I know | rogers711 | investorshub | 07/02/2024 6:46:33 PM |
Its why I said a BO wouldnt happen | CatfishHunter | investorshub | 07/02/2024 6:41:20 PM |
Its why I said a BO wouldnt happen | CatfishHunter | investorshub | 07/02/2024 6:39:23 PM |
It seems buyouts have been for products/companies that | classics99 | investorshub | 07/02/2024 5:58:02 PM |
I bought 2 lots in May/June timeframe that | mc73 | investorshub | 07/02/2024 5:21:18 PM |
Great update! | Tiger Money | investorshub | 07/02/2024 5:20:44 PM |
Do you agree? | PioneerEmpire67 | investorshub | 07/02/2024 5:14:27 PM |
I think he is thinking 3-5 years down | mc73 | investorshub | 07/02/2024 5:12:30 PM |
Good points! I will dial it back | mc73 | investorshub | 07/02/2024 5:11:25 PM |
16's gave me the op to increase my | BBANBOB | investorshub | 07/02/2024 5:10:26 PM |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- By Meg Flippin, Benzinga In what could prove to be a transformational development in cancer treatment, Vivos (OTCQB: RDGL), the maker of the Radiogel™ Precision Radionuclide Therapy, submitted an application to the U.S. Food and Drug Administration (FDA) to init...
Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”). The filing was an amendment, addressing the FDA comments to our previous application (Q211938/S001). Today’...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...